MedTrace Logo

Study Comparing the Tolerability of Seroquel IR With Seroquel XR in Patients With Bipolar Depression

NCT00926393 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 139

Last updated 2011-05-11

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to compare the sedation profile one hour after dose administration between Seroquel IR and Seroquel XR.

Conditions

Interventions

DRUG

Quetiapine Immediate Release

Oral, 3 tablets daily: (2 x 25 mg + 1 x 50 mg) at one time each day

DRUG

Quetiapine Extended Release

Oral, 3 tablets daily: (2 x 25 mg + 1 x 50 mg) at one time each day

Sponsors & Collaborators

Principal Investigators

  • Catherine Datto, MD · AstraZeneca

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2009-08-31
Completion
2009-08-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00926393 on ClinicalTrials.gov